retatrutide at night or morning VisualAbstract: reduces body weight by 17.5% in patients with obesity Retatrutide for Women Over 40:

[DOI] [PMC free article] [PubMed] [Google Scholar] 194.Marini H.R

GLP-1 GLP-1 nonapeptide pentapeptide

2017 Jul 3;16(1):131

Heres what the research shows for weight loss: Tirzepatide Results: Average weight loss: 15-21% of starting body weight Up to 65% of people lost 10% or more of their weight About 31% of people lost 20% or more of their weight Semaglutide Results: Average weight loss: 13-16% of starting body weight Around 73% of people lost 5% or more of their weight About 58% of people lost 10% or more of their weight Real-World Results In real-world clinical settings, people taking tirzepatide were more likely to achieve significant weight loss milestones compared to those taking semaglutide

He worked on a study last year that found that taking a GLP-1 was linked to reduced risk of developing cancer